P301 Addition of pertuzumab (P) to trastuzumab (H)-based neoadjuvant chemotherapy significantly improves pathological complete response in women with HER2-positive early breast cancer: Result of a randomised phase II study (NEOSPHERE)
Titel:
P301 Addition of pertuzumab (P) to trastuzumab (H)-based neoadjuvant chemotherapy significantly improves pathological complete response in women with HER2-positive early breast cancer: Result of a randomised phase II study (NEOSPHERE)
Auteur:
Gianni, L. Pienkowski, T. Im, Y.-H. Roman, L. Tseng, L.-M. Liu, M.-C. Lluch-Hernandez, A. Semiglazov, V. Valagussa, P. Szado, T.